CoChat

Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease

Levey, Allan I., Heilman, Craig J., Lah, James J., Nash, Norman R., Rees, Howard D., Wakai, Masakazu, Mirra, Suzanne S., Rye, David B., Nochlin, David, Bird, Thomas D., Mufson, Elliott J. · 1997 · Annals of Neurology
Cited by 45

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Mutations of the presenilin PS1 and PS2 genes are closely linked to aggressive forms of early‐onset (<60 years) familial Alzheimer's disease. A highly specific monoclonal antibody was developed to identify and characterize the native PS1 protein. Western blot analyses revealed a predominant 32‐kd immunoreactive polypeptide in a variety of samples, including PC12 cells transfected with human PS1 complementary DNA, brain biopsy specimens from demented patients, and postmortem samples of frontal neocortex from early‐onset familial Alzheimer's disease cases (PS1 and PS2), lateonset sporadic Alzheimer's disease cases, and cases of other degenerative disorders. This truncated polypeptide contains the N‐terminus of PS1 and appeared unchaged across cases. In 2 early‐onset cases linked to missense mutations in the PS1 gene, a PS1 immunoreactive protein (∼49 kd) accumulated in the frontal cortex. This protein was similar in size to full‐length PS1 protein present in transfected cells overexpressing PS1 complementary DNA, and in lymphocytes from an affected individual with a deletion of exon 9 of the PS1 gene, suggesting that mutations of the PS1 gene perturb the endoproteolytic processing of the protein. Immunohistochemical studies of control brains revealed that PS1 is expressed primarily in neurons, with the protein localized in the soma and dendritic processes. In contrast, PS1 showed striking localization to the neuropathology in early‐onset familial Alzheimer's disease and sporadic Alzheimer's disease cases. PS1 immunoreactivity was present in the neuritic component of senile plaques as well as in neurofibrillary tangles. Localization of PS1 immunoreactivity in familial and sporadic Alzheimer's disease suggests that genetically heterogeneous forms of the disease share a common pathophysiology involving PS1 protein.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.410410610

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 45

Metadata

Authors
Levey, A. I., Heilman, C. J., Lah, J. J., Nash, N. R., Rees, H. D., Wakai, M., Mirra, S. S., Rye, D. B., Nochlin, D., Bird, T. D., & Mufson, E. J.
Venue
Annals of Neurology
Publisher
Wiley
Published
1997-06
Volume
41
Issue
6
Pages
742-753
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1991142832
Cited by
45
References
12
FWCI
5.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease. https://app.cochat.ai/papers/10.1002/ana.410410610
The paper
Levey, A. I., Heilman, C. J., Lah, J. J., Nash, N. R., Rees, H. D., Wakai, M., Mirra, S. S., Rye, D. B., Nochlin, D., Bird, T. D., & Mufson, E. J. (1997). Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease. Annals of Neurology. https://doi.org/10.1002/ana.410410610

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.